US Patent Issued to Opus Genetics on July 8 for "Aqueous ophthalmic solutions of phentolamine and medical uses thereof" (Illinois Inventor)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,366, issued on July 8, was assigned to Opus Genetics Inc. (Farmington Hills, Mich.).

"Aqueous ophthalmic solutions of phentolamine and medical uses thereof" was invented by Alan Meyer (North Riverside, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water."

The patent was filed on Dec. 13, 2023, under Application N...